Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

LXRXLXRX
Showing 8 of 31 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in LEXICON PHARMACEUTICALS INC

Yes. Charles Schwab Investment Management holds 1,956,775 shares of LXRX (Lexicon Pharmaceuticals), worth $4.7M, as of its Q2 2026 13F filing. It increased the position by 645,477 shares (+49.2%) from Q1 2026. Charles Schwab Investment Management has held LXRX in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$4.7M

Current Shares

2M

Total Value Change

+$2.5M

Total Shares Change

+539,480

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+49.2%
$4.7M0.0%$2.40
37
2026-Q1
Increased
1.3M
+24.3%
$2M0.0%$1.56
32
2025-Q4
Decreased
1.1M
-7.8%
$1.2M0.0%$1.15
0
2025-Q3
Increased
1.1M
+29.6%
$1.5M0.0%$1.35
32
2025-Q2
Decreased
883,227
-23.3%
$835,2680.0%$0.95
0
2025-Q1
Decreased
1.2M
-3.4%
$530,2750.0%$0.46
0
2024-Q4
Decreased
1.2M
-16.0%
$879,6210.0%$0.74
0
2024-Q3
Increased
1.4M
+4.3%
$2.2M0.0%$1.57
27

Other major holders of LXRX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used